Literature DB >> 23836324

Rasch analysis of clinical outcome measures in spinal muscular atrophy.

Stefan J Cano1, Anna Mayhew, Allan M Glanzman, Kristin J Krosschell, Kathryn J Swoboda, Marion Main, Birgit F Steffensen, Carole Bérard, Françoise Girardot, Christine A M Payan, Eugenio Mercuri, Elena Mazzone, Bakri Elsheikh, Julaine Florence, Linda S Hynan, Susan T Iannaccone, Leslie L Nelson, Shree Pandya, Michael Rose, Charles Scott, Reza Sadjadi, Mackensie A Yore, Cynthia Joyce, John T Kissel.   

Abstract

INTRODUCTION: Trial design for SMA depends on meaningful rating scales to assess outcomes. In this study Rasch methodology was applied to 9 motor scales in spinal muscular atrophy (SMA).
METHODS: Data from all 3 SMA types were provided by research groups for 9 commonly used scales. Rasch methodology assessed the ordering of response option thresholds, tests of fit, spread of item locations, residual correlations, and person separation index.
RESULTS: Each scale had good reliability. However, several issues impacting scale validity were identified, including the extent that items defined clinically meaningful constructs and how well each scale measured performance across the SMA spectrum.
CONCLUSIONS: The sensitivity and potential utility of each SMA scale as outcome measures for trials could be improved by establishing clear definitions of what is measured, reconsidering items that misfit and items whose response categories have reversed thresholds, and adding new items at the extremes of scale ranges.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  Rasch analysis; clinical trials; motor neuron disease; outcome measures; spinal muscular atrophy

Mesh:

Year:  2013        PMID: 23836324      PMCID: PMC4376296          DOI: 10.1002/mus.23937

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  41 in total

1.  The gross motor function measure is a valid and sensitive outcome measure for spinal muscular atrophy.

Authors:  Leslie Nelson; Hollis Owens; Linda S Hynan; Susan T Iannaccone
Journal:  Neuromuscul Disord       Date:  2006-05-02       Impact factor: 4.296

Review 2.  Controversy and the Rasch model: a characteristic of incompatible paradigms?

Authors:  David Andrich
Journal:  Med Care       Date:  2004-01       Impact factor: 2.983

3.  FDA draft guidance and health-outcomes research.

Authors:  Dennis A Revicki
Journal:  Lancet       Date:  2007-02-17       Impact factor: 79.321

4.  Validation of the Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND).

Authors:  Allan M Glanzman; Michael P McDermott; Jacqueline Montes; William B Martens; Jean Flickinger; Susan Riley; Janet Quigley; Sally Dunaway; Jessica O'Hagen; Liyong Deng; Wendy K Chung; Rabi Tawil; Basil T Darras; Michele Yang; Douglas Sproule; Darryl C De Vivo; Petra Kaufmann; Richard S Finkel
Journal:  Pediatr Phys Ther       Date:  2011       Impact factor: 3.049

5.  Prospective cohort study of spinal muscular atrophy types 2 and 3.

Authors:  Petra Kaufmann; Michael P McDermott; Basil T Darras; Richard S Finkel; Douglas M Sproule; Peter B Kang; Maryam Oskoui; Andrei Constantinescu; Clifton L Gooch; A Reghan Foley; Michele L Yang; Rabi Tawil; Wendy K Chung; William B Martens; Jacqueline Montes; Vanessa Battista; Jessica O'Hagen; Sally Dunaway; Jean Flickinger; Janet Quigley; Susan Riley; Allan M Glanzman; Maryjane Benton; Patricia A Ryan; Mark Punyanitya; Megan J Montgomery; Jonathan Marra; Benjamin Koo; Darryl C De Vivo
Journal:  Neurology       Date:  2012-10-17       Impact factor: 9.910

6.  Friedreich's ataxia impact scale: a new measure striving to provide the flexibility required by today's studies.

Authors:  Stefan J Cano; Afsane Riazi; Anthony H V Schapira; J Mark Cooper; Jeremy C Hobart
Journal:  Mov Disord       Date:  2009-05-15       Impact factor: 10.338

7.  Reliability of 4 outcome measures in pediatric spinal muscular atrophy.

Authors:  Susan T Iannaccone; Linda S Hynan
Journal:  Arch Neurol       Date:  2003-08

8.  Validity of the TIMPSI for estimating concurrent performance on the test of infant motor performance.

Authors:  Suzann K Campbell; Andrew Swanlund; Everett Smith; Pai-Jun Liao; Laura Zawacki
Journal:  Pediatr Phys Ther       Date:  2008       Impact factor: 3.049

9.  Moving towards meaningful measurement: Rasch analysis of the North Star Ambulatory Assessment in Duchenne muscular dystrophy.

Authors:  Anna Mayhew; Stefan Cano; Elaine Scott; Michelle Eagle; Kate Bushby; Francesco Muntoni
Journal:  Dev Med Child Neurol       Date:  2011-03-17       Impact factor: 5.449

10.  The problem with health measurement.

Authors:  Stefan J Cano; Jeremy C Hobart
Journal:  Patient Prefer Adherence       Date:  2011-06-14       Impact factor: 2.711

View more
  17 in total

Review 1.  The Genetics of Spinal Muscular Atrophy: Progress and Challenges.

Authors:  Michelle A Farrar; Matthew C Kiernan
Journal:  Neurotherapeutics       Date:  2015-04       Impact factor: 7.620

2.  Using Rasch Analysis to Validate the Michigan Hand Outcomes Questionnaire from the Wrist and Radius Injury Surgical Trial.

Authors:  Mayank Jayaram; Chang Wang B S; Melissa J Shauver; Lu Wang; Kevin C Chung
Journal:  Plast Reconstr Surg       Date:  2021-10-01       Impact factor: 5.169

Review 3.  Spinal muscular atrophy: development and implementation of potential treatments.

Authors:  W David Arnold; Arthur H M Burghes
Journal:  Ann Neurol       Date:  2013-09       Impact factor: 10.422

4.  Rasch analysis of the motor function measure in patients with congenital muscle dystrophy and congenital myopathy.

Authors:  Carole Vuillerot; Pascal Rippert; Virginie Kinet; Anne Renders; Minal Jain; Melissa Waite; Allan M Glanzman; Francoise Girardot; Dalil Hamroun; Jean Iwaz; René Ecochard; Susana Quijano-Roy; Carole Bérard; Isabelle Poirot; Carsten G Bönnemann
Journal:  Arch Phys Med Rehabil       Date:  2014-06-25       Impact factor: 3.966

5.  Motor Function Test Reliability During the NeuroNEXT Spinal Muscular Atrophy Infant Biomarker Study.

Authors:  Kristin J Krosschell; Michael Bosch; Leslie Nelson; Tina Duong; Linda P Lowes; Lindsay N Alfano; Danielle Benjamin; Terri B Carry; Ginger Devine; Carolyn Kelley; Rebecca Gadekan; Elizabeth C Malkus; Amy Pasternak; Stephanie Provance-Orr; Lynne Roemeiser-Logan; Alina Nicorici; Donata Trussell; Sally Dunaway Young; Jennifer R Fetterman; Jacqueline Montes; Penny J Powers; Rebecca Quinones; Janet Quigley; Christopher S Coffey; Jon W Yankey; Amy Bartlett; John T Kissel; Stephen J Kolb
Journal:  J Neuromuscul Dis       Date:  2018

6.  Upper limb evaluation and one-year follow up of non-ambulant patients with spinal muscular atrophy: an observational multicenter trial.

Authors:  Andreea Mihaela Seferian; Amélie Moraux; Aurélie Canal; Valérie Decostre; Oumar Diebate; Anne Gaëlle Le Moing; Teresa Gidaro; Nicolas Deconinck; Frauke Van Parys; Wendy Vereecke; Sylvia Wittevrongel; Mélanie Annoussamy; Michèle Mayer; Kim Maincent; Jean-Marie Cuisset; Vincent Tiffreau; Severine Denis; Virginie Jousten; Susana Quijano-Roy; Thomas Voit; Jean-Yves Hogrel; Laurent Servais
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.240

7.  Feasibility of Using Microsoft Kinect to Assess Upper Limb Movement in Type III Spinal Muscular Atrophy Patients.

Authors:  Xing Chen; Juliane Siebourg-Polster; Detlef Wolf; Christian Czech; Ulrike Bonati; Dirk Fischer; Omar Khwaja; Martin Strahm
Journal:  PLoS One       Date:  2017-01-25       Impact factor: 3.240

8.  Longitudinal characterization of biomarkers for spinal muscular atrophy.

Authors:  Ulrike Bonati; Štefan Holiga; Nicole Hellbach; Céline Risterucci; Tobias Bergauer; Wakana Tang; Patricia Hafner; Alain Thoeni; Oliver Bieri; Irene Gerlach; Anne Marquet; Omar Khwaja; Fabio Sambataro; Alessandro Bertolino; Juergen Dukart; Arne Fischmann; Dirk Fischer; Christian Czech
Journal:  Ann Clin Transl Neurol       Date:  2017-04-11       Impact factor: 4.511

9.  Revised Hammersmith Scale for spinal muscular atrophy: A SMA specific clinical outcome assessment tool.

Authors:  Danielle Ramsey; Mariacristina Scoto; Anna Mayhew; Marion Main; Elena S Mazzone; Jacqueline Montes; Roberto de Sanctis; Sally Dunaway Young; Rachel Salazar; Allan M Glanzman; Amy Pasternak; Janet Quigley; Elizabeth Mirek; Tina Duong; Richard Gee; Matthew Civitello; Gihan Tennekoon; Marika Pane; Maria Carmela Pera; Kate Bushby; John Day; Basil T Darras; Darryl De Vivo; Richard Finkel; Eugenio Mercuri; Francesco Muntoni
Journal:  PLoS One       Date:  2017-02-21       Impact factor: 3.240

10.  Hyperleptinemia in children with autosomal recessive spinal muscular atrophy type I-III.

Authors:  Heike Kölbel; Berthold P Hauffa; Stefan A Wudy; Anastasios Bouikidis; Adela Della Marina; Ulrike Schara
Journal:  PLoS One       Date:  2017-03-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.